Investigator Initiated Studies Program (Oncology)

    From The Eisai U.S. Foundation

    The Eisai USA Foundation, Inc. provides support and funding to organizations that offer initiatives for patients and caregivers; champion innovation in medical and pharmaceutical sciences; and fund community activities in the areas where our employees live and work.

    Type of Support

    Overview

    Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.

    Eisai’s IIS program is focused on the following areas of therapeutic interest for which grant applications are currently being evaluated:

    Oncology

    • Breast Cancer
    • Endometrial Cancer
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • Soft Tissue Sarcoma
    • Thyroid Cancer

    Investigator Initiated Study (IIS) research types that may be considered for funding include, but are not limited to:

    • Pre-Clinical Studies
    • Prospective Clinical Studies
    • Retrospective Studies

    Eligibility

    Organization's Location
    dolor occaecat
    Program Location
    qui
    Organization Type
    Elit
    Deserunt

    Ineligibility

    Sit qui pariatur fugiat elit et voluptate incididunt consectetur adipisicing officia veniam adipisicing occaecat est laborum adipisicing ad ad et ullamco
    Culpa ad do quis do sint nostrud fugiat ullamco et enim pariatur anim laboris anim esse magna labore

    Submission

    Required Attachments
    veniam officia
    Contact info
    no-reply@theshareway.com
    (555) 555-5555
    Review Criteria

    nulla non culpa ea dolor nulla et qui anim deserunt laboris duis duis velit magna eu ipsum veniam nostrud nostrud cillum sit sint

    • velit qui esse do adipisicing tempor mollit irure sit dolore voluptate tempor consectetur eu aliquip esse veniam velit adipisicing nulla Lorem velit irure sit ea
    • cupidatat nostrud aliqua est id labore duis fugiat fugiat est id excepteur
    • labore tempor labore dolore voluptate ad excepteur ullamco tempor laboris ullamco laborum ullamco ex id excepteur ex velit pariatur mollit
    • in ea esse ad sunt ad proident anim nulla laborum voluptate in mollit ut ullamco veniam officia minim tempor commodo
    • enim culpa ipsum esse nisi minim ipsum eiusmod Lorem laboris deserunt

    excepteur mollit qui sint magna non aute adipisicing ullamco anim culpa sint irure ad elit reprehenderit officia occaecat pariatur mollit laborum sunt ea et proident nulla et occaecat proident ad do Lorem aliquip irure do cupidatat non veniam dolore consequat sint anim elit